These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17981480)

  • 21. Telomerase inhibition: the way ahead for cancer therapy in humans and dogs?
    Colitz CM
    Vet J; 2008 Aug; 177(2):153-4. PubMed ID: 18171631
    [No Abstract]   [Full Text] [Related]  

  • 22. Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate.
    Kondo Y; Kondo S
    Methods Mol Biol; 2007; 405():97-112. PubMed ID: 18369820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of tumor cell growth in the liver by RNA interference-mediated suppression of HIF-1alpha expression in tumor cells and hepatocytes.
    Takahashi Y; Nishikawa M; Takakura Y
    Gene Ther; 2008 Apr; 15(8):572-82. PubMed ID: 18273056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase reverse transcriptase (TERT) expression and proliferation in canine brain tumours.
    Long S; Argyle DJ; Nixon C; Nicholson I; Botteron C; Olby N; Platt S; Smith K; Rutteman GR; Grinwis GC; Nasir L
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):662-73. PubMed ID: 17083480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNAi-mediated knockdown of target genes: a promising strategy for pancreatic cancer research.
    Chang H
    Cancer Gene Ther; 2007 Aug; 14(8):677-85. PubMed ID: 17541422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models.
    Fu W; Chu L; Han X; Liu X; Ren D
    J Gene Med; 2008 Jun; 10(6):690-701. PubMed ID: 18338832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
    Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
    J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibitory effect of RNAi targeting human telomerase reverse transcriptase against human hepatocellular carcinoma cells].
    Li H; Wang XL; Yang Y; Zhang J; Wang GS; Jiang N; Chen GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1323-6. PubMed ID: 18753050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of telomerase activity in cancer cells using short hairpin RNA expression vectors.
    Chen SM; Tao ZZ; Hua QQ; Xiao BK; Xu Y; Wang Y; Deng YQ
    Cancer Invest; 2007 Dec; 25(8):691-8. PubMed ID: 18058464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA.
    Zheng JN; Pei DS; Mao LJ; Liu XY; Mei DD; Zhang BF; Shi Z; Wen RM; Sun XQ
    Cancer Gene Ther; 2009 Jan; 16(1):20-32. PubMed ID: 18690204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition.
    Yoo JY; Kim JH; Kim J; Huang JH; Zhang SN; Kang YA; Kim H; Yun CO
    Gene Ther; 2008 May; 15(9):635-51. PubMed ID: 18273054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lentivirus-mediated short hairpin RNA targeting the APRIL gene suppresses the growth of pancreatic cancer cells in vitro and in vivo.
    Wang F; Chen L; Mao ZB; Shao JG; Tan C; Huang WD
    Oncol Rep; 2008 Jul; 20(1):135-9. PubMed ID: 18575728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
    ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
    Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo reversal of P-glycoprotein-mediated multidrug resistance by efficient delivery of stealth RNAi.
    Xiao H; Wu Z; Shen H; Luo AL; Yang YF; Li XB; Zhu DY
    Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):342-8. PubMed ID: 18834355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic studies coupled with RNAi methodologies can shed further light on the downstream effects of telomerase in glioma.
    Thakkar D; Shervington L; Shervington A
    Cancer Invest; 2011 Feb; 29(2):113-22. PubMed ID: 21261472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase as a target for cancer therapy.
    Parkinson KE
    Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
    Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C
    Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomerase and the search for the end of cancer.
    Mocellin S; Pooley KA; Nitti D
    Trends Mol Med; 2013 Feb; 19(2):125-33. PubMed ID: 23253475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transkingdom RNA interference (tkRNAi): a novel method to induce therapeutic gene silencing.
    Nguyen TA; Fruehauf JH
    Methods Mol Biol; 2009; 514():27-34. PubMed ID: 19048211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.